MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
MAX dimerization protein 3 (MXD3), a transcriptional regulator of the MXD3 superfamily, is a part of the MYC–MAX–MXD network. However, its role in tumors has been reported in several cancers, such as B-cell acute lymphoblastic leukemia, medulloblastoma, neuroblastoma, and glioblastoma. Based on TCGA...
Guardado en:
Autores principales: | Xiaoyu Zhang, Xiaoqin He, Yue Li, Yangtao Xu, Wenliang Chen, Xin Liu, Xinyao Hu, Lin Xiong, Ximing Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/03a918ac26324d8abc5c93749ca89d8d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
por: Xin Jin, et al.
Publicado: (2021) -
Prognostic role of oxytocin receptor in colon adenocarcinoma
por: Sun Junjie, et al.
Publicado: (2021) -
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
por: Guojun Lu, et al.
Publicado: (2021) -
Methylation and Expression of the Exercise-Related TLR1 Gene Is Associated With Low Grade Glioma Prognosis and Outcome
por: Lichun Lu, et al.
Publicado: (2021) -
Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
por: Susu Zheng, et al.
Publicado: (2021)